Zinzani PL, Thieblemont C, Melnichenko V, et al. Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170. Blood. 2023;142(2):141-145

Blood. 2024 Mar 28;143(13):1316. doi: 10.1182/blood.2024024192.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Thymus Neoplasms*

Substances

  • pembrolizumab
  • Antibodies, Monoclonal, Humanized